Skip to main content
Equibles

ACADIAN ASSET MANAGEMENT LLC

Position in NCNA — NuCana plc

CIK 916542 Boston, MA
Back to NCNA Full portfolio

Position in NCNA

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$3
+$1 QoQ
Shares Held
2
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#8
of 10 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NCNA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

ACADIAN ASSET MANAGEMENT LLC holds $732,389,014 across 168 Biotechnology names. NCNA ranks #167 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 INCY
Incyte Corp
 1,664,999 $188,744,286
2 REGN
Regeneron Pharmaceuticals, Inc.
 157,440 $98,170,137
3 IMCR
Immunocore Holdings plc
 1,209,894 $38,414,134
4 RIGL
Rigel Pharmaceuticals Inc
 591,686 $23,146,756
5 EXEL
Exelixis, Inc.
 421,444 $22,930,768
6 VRTX
Vertex Pharmaceuticals Inc / Ma
 42,122 $20,923,261
7 TBPH
Theravance Biopharma, Inc.
 1,174,910 $19,973,470
8 PRTA
Prothena Corp Public Ltd Co
 2,010,645 $19,684,214

All Filings in NCNA

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3 2
2026-03-31 $2 2
2025-12-31 $7 2
2025-09-30 $9 2
2025-06-30 $23 414
2025-03-31 $33,454 38,321
2024-12-31 $50,473 42,415
2024-09-30 $54,335 23,624
2024-06-30 $60,241 23,624
2024-03-31 $153,569 590,651
2023-12-31 $174,832 590,651
2023-09-30 $360,297 590,651
2023-06-30 $466,614 590,651
2023-03-31 $567,024 590,651
2022-12-31 $389,829 590,651
2022-09-30 $617,230 590,651
2022-06-30 $396,606 547,043
2022-03-31 $522,009 522,532
2021-12-31 $472,482 198,522
2021-09-30 $996,202 386,125
2021-06-30 $459,736 165,970
2021-03-31 $84,889 17,012